Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
5 Key Sample Management Automation Trends for 2025- 2026: An Interview with SPT Labtech’s Cory Tiller
Continue reading
Delivering Sustainable Science: SPT Labtech Validates GHG Reduction Targets to Meet Customer Needs
Continue reading
SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform
Continue reading
Explore insightful resources that include videos, whitepapers, eBooks, application notes and more
In this talk, we’ll look at how SPT Labtech’s mosquito liquid handlers are helping labs tackle those pressures head-on, by enabling reliable, low-volume workflows that are both efficient and scalable. We’ll cover how mosquito is being used in a wide range of applications: from miniaturized NGS and single-cell omics to compound screening to nanoscale chemistry.
Read moreExplore our flyer for mosquito and its use in nanoscale synthesis and how it is advancing chemistry with ultra-low volume reactions.
Read moreExplore our flyer on compound screening and validation with mosquito® and how to reduce assay costs without compromising performance
Read moreDownload our latest flyer to explore our dynamic duo for low-volume liquid handling for genomics. Explore the mosquito® and dragonfly® increases your productivity and reduces the cost per sample by miniaturizing your NGS method with proven workflow solutions for over 40 NGS kits, including industry standards such as Illumina Nextera XT, Illumina DNA Prep, NEBNext Ultra II, plus many more.
Read moreDownload our latest flyer for the mosquito® X1 to discover the key benefits and how it achieves high speed low volume cherry picking.
Read moreDownload our latest flyer for the mosquito® HV to discover the key benefits and how it is bridging the nanolitre to microlitre gap.
Read moreDownload our latest flyer for the mosquito® Gen3 to explore its key benefits and how it is lowering the barrier to NGS miniaturization.
Read moreExplore our latest flyer for the mosquito® LV to discover the key benefits and how it is making high throughput assay miniaturization simple.
Read moreIn this webinar, learn how the team at Artios Pharma have developed and implemented automated end-to-end workflows for sample storage and tracking, processing, assay-ready plate generation and sample mapping for analysis, using Titian Sample Bank software and SPT Labtech automation systems. Using this compound management workflow, they have demonstrated up to a 40% reduction in data posting cycle times and decreased running costs, as well as using the system for clinical sample supply and tracking, all of which results in quicker data reporting to drive decision making and more effective use of resources.
Read moreIntroducing our most compact and accessible member of the mosquito family. mosquito Gen3 offers highly accurate and precise multi-channel pipetting from 500 nL to 5 µL, allowing genomics researchers to benefit from miniaturization across a range of applications, irrespective of liquid class. The instrument’s rapid plate-to-plate pipetting motion and tip exchange maximize speed and efficiency.
Read moreThis application note highlights how mosquito HV genomics has been used to automate the Illumina Nextera XT protocol at SEQ-IT, achieving 5X miniaturized reaction volumes while delivering reproducible, high-quality libraries. Based in Kaiserslautern in Germany, SEQ-IT is a mid-sized company offering both Sanger sequencing and NGS services.
Read moreThis poster highlights how mosquito HV genomics has been used to automate the Illumina Nextera XT protocol at SEQ-IT, achieving 5X miniaturized reaction volumes while delivering reproducible, high-quality libraries. This miniaturized method was developed to identify and screen mutations with oncogenic potential and drug resistance (HIV, HBV, HCV), SNP detection, as well as in HLA-typing, among other applications.
Read more